Last update: Dec. 1, 2004

Lisuride

Very High Risk for breastfeeding


Very unsafe. Contraindicated.
Use of an alternative or cessation of breastfeeding.

Anti-Parkinson drug, dopamine-agonist and synthetic ergotamine derivative that may inhibit prolactin release.

Alternatives

We do not have alternatives for Lisuride.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Lisuride is also known as


Group

Lisuride belongs to this group or family:

Tradenames

Main tradenames from several countries containing Lisuride in its composition:

Pharmacokinetics

Variable Value Unit
Bioavailability 22 %
Molecular weight 339 daltons
Protein Binding 66 %
Tmax 1 hours
T1/2 3 hours

References

  1. [No authors listed] Do not use drugs to prevent onset of lactation. Relieve the discomfort and wait. Prescrire Int. 2013 Abstract

Total visits

2,099

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM